NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 10477.30 -216.40 -2.02%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Inovio Pharmaceuticals, Inc. (AMEX: INO)

 

INO Share Price

Open 5.85 Change Price %
High 5.92 1 Day 0.01 0.17
Low 5.78 1 Week 0.00 0.00
Close 5.83 1 Month -0.41 -6.57
Volume 698357 1 Year -1.99 -25.45
52 Week High 9.86
52 Week Low 5.28
 
INO Technical Analysis
4
As on 31st Oct 2017 INO Share Price closed @ 5.83 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.65 & Sell for SHORT-TERM with Stoploss of 6.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
NGD 3.29 -6.80%
RBY 0.03 -70.00%
LODE 0.12 -7.69%
PBTH 8.23 0.37%
GGR 0.02 100.00%
VTG 0.05 -16.67%
SYRG 8.13 0.87%
GSX 0.02 0.00%
SHZ 0.10 -16.67%
 
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
 
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
LBY 6.84 -25.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
 
 
INO
Daily Charts
INO
Intraday Charts
Whats New @
Bazaartrend
INO
Free Analysis
 
INO Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE5.96
RESISTANCE5.91
SUPPORT5.75
SUPPORT5.70
SUPPORT0.00
SUPPORT0.00
 
INO Target for Month December
4th UP TARGET8.62
3rd UP TARGET7.73
2nd UP TARGET7.17
1st UP TARGET6.62
1st DOWN TARGET5.04
2nd DOWN TARGET4.49
3rd DOWN TARGET3.93
4th DOWN TARGET3.04
 
INO Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
INO Target for Year 2018
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
INO Other Details
Segment EQ
Market Capital 89092640.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.inovio.com
 
INO Address
INO
Building 18
Suite 400
Blue Bell, PA 19422
United States
Phone: 267-440-4200
Fax: 267-440-4242
 
INO Latest News
 
Your Comments and Response on Inovio Pharmaceuticals, Inc.
 
INO Business Profile
Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company’s DNA-based SynCon technology designed to provide protection against known and new unmatched strains of pathogens, such as influenza. Its electroporation DNA delivery technology uses controlled electrical pulses to enhance cellular DNA vaccine uptake. The company’s clinical programs include HPV-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus, hepatitis B virus, HIV, and malaria vaccines. It is also advancing preclinical research for a seasonal/pandemic influenza vaccine, as well as other products. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Blue Bell, Pennsylvania.
 
© 2005-2018 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service